SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 29 filers reported holding SIERRA ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $307,000 | -27.3% | 786,773 | +4.3% | 0.88% | +171.5% |
Q2 2019 | $422,000 | +111.0% | 754,231 | +544.0% | 0.33% | +219.6% |
Q1 2019 | $200,000 | +48.1% | 117,115 | +157.4% | 0.10% | +100.0% |
Q2 2018 | $135,000 | -34.8% | 45,500 | -54.5% | 0.05% | -33.8% |
Q1 2018 | $207,000 | – | 100,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 8,112,121 | $13,872,000 | 3.34% |
New Leaf Venture Partners, L.L.C. | 5,020,446 | $8,585,000 | 2.35% |
Abingworth LLP | 1,365,027 | $2,307,000 | 2.06% |
Prosight Management, LP | 2,457,683 | $4,203,000 | 1.84% |
Broadfin Capital, LLC | 4,829,832 | $8,259,000 | 1.70% |
MANGROVE PARTNERS IM, LLC | 3,688,609 | $6,308,000 | 0.84% |
Vivo Capital, LLC | 2,438,270 | $4,169,000 | 0.42% |
683 Capital Management, LLC | 2,313,159 | $3,956,000 | 0.36% |
PA Capital LLC | 138,082 | $236,000 | 0.25% |
ARMISTICE CAPITAL, LLC | 1,560,000 | $2,668,000 | 0.15% |